Opus Genetics, Inc. (IRD) — Net Asset Momentum
Opus Genetics, Inc. (IRD) recorded a net asset momentum of 128.3% as of December 2025, with net assets of $15.35 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See operational self-sufficiency of Opus Genetics, Inc. to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Opus Genetics, Inc. Net Asset Momentum (2019–2025)
This chart tracks Opus Genetics, Inc.'s year-over-year net asset growth across 7 annual reporting periods from 2019 to 2025. The most recent momentum reading is +128.3%, with net assets of $15.35 Million USD as of December 2025. Read total liabilities of Opus Genetics, Inc. for a breakdown of total debt and financial obligations.
Annual Net Asset History for Opus Genetics, Inc. (2019–2025)
The table below shows the complete annual net asset history for Opus Genetics, Inc. from 2019 to 2025, covering 7 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Opus Genetics, Inc. (IRD) total market value.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $15.35 Million | $50.24 Million | $34.90 Million | ▲ +128.3% |
| 2024 | $6.72 Million | $36.86 Million | $30.14 Million | ▼ -86.5% |
| 2023 | $49.91 Million | $53.95 Million | $4.04 Million | ▲ +7.9% |
| 2022 | $46.24 Million | $48.99 Million | $2.75 Million | ▲ +108.1% |
| 2021 | $22.22 Million | $26.08 Million | $3.85 Million | ▲ +265.0% |
| 2020 | $-13.47 Million | $17.68 Million | $31.15 Million | ▼ -78.1% |
| 2019 | $-7.56 Million | $1.78 Million | $9.34 Million | — |